A methanolic extract from Solanum torvum fruits exhibited inhibitory activity against the angiotensin-converting enzyme (ACE) with an IC50 value of 1.2 mg/mL. On the basis of a bioassay-guided isolation, an ACE inhibitory active compound, namely (E)-2,3-dihydroxycyclopentyl-3-(3′,4′-dihydroxyphenyl)acrylate (1) (IC50 of 778 µg/mL), was obtained, together with a novel methyl salicylate glycoside – torvumoside [methyl salicylate 2-O-(2′-O-β-apiofuranosyl, 6′-O-β-xylopyranosyl)-β-glucopyranoside] (3) and a known compound, lariciresinol-4,4′-O-β-D-diglucoside (2). This is the first report of these compounds in this plant.
No takes yet. Share an insight, caveat, or question.
Simaratanamongkol et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: